Invention Grant
- Patent Title: Monoclonal antibodies against HER2
-
Application No.: US15832337Application Date: 2017-12-05
-
Publication No.: US11091553B2Publication Date: 2021-08-17
- Inventor: Bart De Goeij , Simone De Haij , Thilo Riedl , Rene Hoet , Ole Baadsgaard , Jan Van De Winkel , David Satijn , Paul Parren , Aran Frank Labrijn , Joyce Meesters , Janine Schuurman , Edward N. Van Den Brink
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: DKPA201000467 20100527,DKPA201100312 20110420,WOPCT/EP2011/056388 20110420
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/32 ; A61K39/00
Abstract:
Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Public/Granted literature
- US20180215827A1 MONOCLONAL ANTIBODIES AGAINST HER2 Public/Granted day:2018-08-02
Information query
